Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study
- DOI
- 10.1016/s2213-8587(25)00362-6
- Published
- 2026-04
- Container
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2213-8587-25-00362-6,
title = {Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study},
author = {Rosario Pivonello and Giorgio Arnaldi and Richard J Auchus and Corin Badiu and Robert S Busch and Salvatore Cannavò and Ulrich Dischinger and Georgiana A Dobri and Diane M Donegan and Atanaska Elenkova and Pouneh K Fazeli and Richard A Feelders and Rogelio Garcia-Centeno and Aleksandra Gilis-Januszewska and Oksana Hamidi and Zeina C Hannoush and Atil Y Kargi and Harold J Miller and Aurelian-Emil Ranetti and Monica Recasens and Martin Reincke and Sergio Rovner and Roberto Salvatori and Julie Silverstein and Antonio Stigliano and Massimo Terzolo and Christina Wang and Kevin C J Yuen and Amanda Kesner-Hays and Austin L Hand and Iulia Cristina Tudor and Katherine A Araque and Andreas G Moraitis and Lisa Abbott and Amer Al-Karadsheh and Carmen Aresta and Giorgio Arnaldi and Richard J Auchus and Corin Badiu and Isabelle Bourdeau and Robert Busch and Salvatore Cannavò and Iwona Chmiel-Perzyńska and Ulrich Dischinger and Georgiana Dobri and Diane Donegan and Rivka Dresner-Pollak and Andjela Drincic and Honey E East and Atanaska Elenkova and Martin Fassnacht and Pouneh Fazeli and Richard A Feelders and Rogelio Garcia-Centeno and Eliza Geer and Aleksandra Gilis-Januszewska and Murray B Gordon and Yona Greenman and Oksana Hamidi and Zeina Hannoush and Anthony Heaney and Wenyu Huang and Syed A Imran and Andrea Isidori and Serge Jabbour and Atil Y Kargi and Daniel Katselnik and Alexandra Kautzky-Willer and Lawrence S Kirschner and Alice Levine and Jonea Lim and Francisco JT Maduerio and Marianna Martino and Joseph W Mathews and Harold Miller and Le Min and Dan Niculescu and Jean J Nya-Ngatchou and Jonathan Ownby and John C Parker and Antonio M Picó Alfonso and Rosario Pivonello and Cristina Preda and Aurelian-Emil Ranetti and Monica Recasens and Martin Reincke and Leszek Romanowski and Pnina Rotman-Pikielny and Sergio S Rovner and Isaac Sachmechi and Roberto Salvatori and Carla Scaroni and Ilan Shimon and Julie Silverstein and Alfonso Soto-Moreno and Antonio Stigliano and Massimo Terzolo and Christina Wang and Kevin CJ Yuen},
year = {2026},
journal = {The Lancet Diabetes \& Endocrinology},
doi = {10.1016/s2213-8587(25)00362-6},
url = {https://doi.org/10.1016/s2213-8587(25)00362-6}
}RIS
TY - JOUR TI - Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study AU - Rosario Pivonello AU - Giorgio Arnaldi AU - Richard J Auchus AU - Corin Badiu AU - Robert S Busch AU - Salvatore Cannavò AU - Ulrich Dischinger AU - Georgiana A Dobri AU - Diane M Donegan AU - Atanaska Elenkova AU - Pouneh K Fazeli AU - Richard A Feelders AU - Rogelio Garcia-Centeno AU - Aleksandra Gilis-Januszewska AU - Oksana Hamidi AU - Zeina C Hannoush AU - Atil Y Kargi AU - Harold J Miller AU - Aurelian-Emil Ranetti AU - Monica Recasens AU - Martin Reincke AU - Sergio Rovner AU - Roberto Salvatori AU - Julie Silverstein AU - Antonio Stigliano AU - Massimo Terzolo AU - Christina Wang AU - Kevin C J Yuen AU - Amanda Kesner-Hays AU - Austin L Hand AU - Iulia Cristina Tudor AU - Katherine A Araque AU - Andreas G Moraitis AU - Lisa Abbott AU - Amer Al-Karadsheh AU - Carmen Aresta AU - Giorgio Arnaldi AU - Richard J Auchus AU - Corin Badiu AU - Isabelle Bourdeau AU - Robert Busch AU - Salvatore Cannavò AU - Iwona Chmiel-Perzyńska AU - Ulrich Dischinger AU - Georgiana Dobri AU - Diane Donegan AU - Rivka Dresner-Pollak AU - Andjela Drincic AU - Honey E East AU - Atanaska Elenkova AU - Martin Fassnacht AU - Pouneh Fazeli AU - Richard A Feelders AU - Rogelio Garcia-Centeno AU - Eliza Geer AU - Aleksandra Gilis-Januszewska AU - Murray B Gordon AU - Yona Greenman AU - Oksana Hamidi AU - Zeina Hannoush AU - Anthony Heaney AU - Wenyu Huang AU - Syed A Imran AU - Andrea Isidori AU - Serge Jabbour AU - Atil Y Kargi AU - Daniel Katselnik AU - Alexandra Kautzky-Willer AU - Lawrence S Kirschner AU - Alice Levine AU - Jonea Lim AU - Francisco JT Maduerio AU - Marianna Martino AU - Joseph W Mathews AU - Harold Miller AU - Le Min AU - Dan Niculescu AU - Jean J Nya-Ngatchou AU - Jonathan Ownby AU - John C Parker AU - Antonio M Picó Alfonso AU - Rosario Pivonello AU - Cristina Preda AU - Aurelian-Emil Ranetti AU - Monica Recasens AU - Martin Reincke AU - Leszek Romanowski AU - Pnina Rotman-Pikielny AU - Sergio S Rovner AU - Isaac Sachmechi AU - Roberto Salvatori AU - Carla Scaroni AU - Ilan Shimon AU - Julie Silverstein AU - Alfonso Soto-Moreno AU - Antonio Stigliano AU - Massimo Terzolo AU - Christina Wang AU - Kevin CJ Yuen PY - 2026 JO - The Lancet Diabetes & Endocrinology DO - 10.1016/s2213-8587(25)00362-6 UR - https://doi.org/10.1016/s2213-8587(25)00362-6 ER -
APA
Pivonello, R., Arnaldi, G., Auchus, R. J., Badiu, C., Busch, R. S., Cannavò, S., Dischinger, U., Dobri, G. A., Donegan, D. M., Elenkova, A., Fazeli, P. K., Feelders, R. A., Garcia-Centeno, R., Gilis-Januszewska, A., Hamidi, O., Hannoush, Z. C., Kargi, A. Y., Miller, H. J., Ranetti, A., Recasens, M., Reincke, M., Rovner, S., Salvatori, R., Silverstein, J., Stigliano, A., Terzolo, M., Wang, C., Yuen, K. C. J., Kesner-Hays, A., Hand, A. L., Tudor, I. C., Araque, K. A., Moraitis, A. G., Abbott, L., Al-Karadsheh, A., Aresta, C., Arnaldi, G., Auchus, R. J., Badiu, C., Bourdeau, I., Busch, R., Cannavò, S., Chmiel-Perzyńska, I., Dischinger, U., Dobri, G., Donegan, D., Dresner-Pollak, R., Drincic, A., East, H. E., Elenkova, A., Fassnacht, M., Fazeli, P., Feelders, R. A., Garcia-Centeno, R., Geer, E., Gilis-Januszewska, A., Gordon, M. B., Greenman, Y., Hamidi, O., Hannoush, Z., Heaney, A., Huang, W., Imran, S. A., Isidori, A., Jabbour, S., Kargi, A. Y., Katselnik, D., Kautzky-Willer, A., Kirschner, L. S., Levine, A., Lim, J., Maduerio, F. J., Martino, M., Mathews, J. W., Miller, H., Min, L., Niculescu, D., Nya-Ngatchou, J. J., Ownby, J., Parker, J. C., Alfonso, A. M. P., Pivonello, R., Preda, C., Ranetti, A., Recasens, M., Reincke, M., Romanowski, L., Rotman-Pikielny, P., Rovner, S. S., Sachmechi, I., Salvatori, R., Scaroni, C., Shimon, I., Silverstein, J., Soto-Moreno, A., Stigliano, A., Terzolo, M., Wang, C., & Yuen, K. C. (2026). Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(25)00362-6
Source records
- crossref · retrieved 2026-09-27T00:45:35.067Z